Home » Speciality Sections » Translational Toxicology speciality section

Translational Toxicology speciality section

Key information

Co-ordinators:  Dr Keith McLuckie & Dr Lucy Smith

Get in touch:      translationaltox@thebts.org

An important area of toxicology is in the support of development of new medical products (pharmaceuticals and medical devices), where worldwide regulatory authorities have requirements to test these potential treatments in various in vitro and in vivo systems before they can be given to/used by healthy subjects or patients within clinical trials, and subsequently marketed.

Translational Toxicology, as applied to the development of medical products, is a constantly evolving field. Here an understanding of new advances in testing methodologies and capabilities, disease and safety testing models needs to be combined with awareness of effective regulatory strategies for different product types and for the different regulatory authorities.

This speciality section works to enhance understanding of nonclinical aspects of medical product development in the UK’s pharmaceutical, medical device and toxicology industries.